Healthcare Industry News: abdominal aortic aneurysm
News Release - April 28, 2009
Gore Announces Availability of Larger Diameter, Small Profile GORE EXCLUDER AAA EndoprosthesisMinimally Invasive Treatment Now Available to Broader Patient Population
FLAGSTAFF, Ariz.--(HSMN NewsFeed)--W. L. Gore & Associates (Gore) today announced the May 4, 2009 availability of a 31 mm diameter version of the GORE EXCLUDER(R) AAA Endoprosthesis. The device provides physicians with a safe and effective endovascular option to treat abdominal aortic aneurysms (AAAs) in patients with aortic inner neck diameters up to 29 mm. Other important enhancements include a flat-top design that enables greater production efficiency, an additional pair of proximal anchors to help ensure excellent fixation, and a lengthening of the trunk from 7 to 8 cm to accommodate larger anatomies.
More than 87,000 GORE EXCLUDER Devices have been implanted in patients worldwide, making it a widely accepted, minimally invasive treatment option for individuals with AAA. In March 2009, the US Food and Drug Administration (FDA) approved the 31 mm diameter version. It has been available outside of the US since 2004 and has been implanted in more than 3,300 patients.
AAA involves swelling or bulging of the abdominal aorta. When the condition is not treated it can lead to aortic rupture, which is often fatal. Traditional surgical treatment requires a large incision to place a synthetic graft to repair the diseased artery. This method can result in long hospital stays and painful recoveries. The GORE EXCLUDER AAA Endoprosthesis, in contrast, uses a minimally invasive procedure, thereby reducing the hospital stay, morbidity and mortality associated with surgery.
The Gore device is an endovascular graft and stent combination that seals off the aneurysm and creates a new path for blood flow. The device is inserted through a small incision in the patient’s leg using a catheter-based delivery technique. Once the physician has positioned the graft in the diseased aorta, the device self-expands using radial force. Metal anchors help secure it to the walls of the aorta.
Dr. Jon Matsumura, National Principal Investigator, stated, “The availability of the larger aortic diameter GORE EXCLUDER Devices will certainly broaden the range of American patients that can have their aneurysms treated with endovascular repair. This less invasive option has clear benefits of more rapid recovery and lower postoperative risk of fatal complications compared to open surgical repair.”
The 31 mm GORE EXCLUDER Device is available in 13, 15 and 17 cm lengths. A new 32 mm x 4.5 cm Aortic Extender Component joins the device family as well. Both the new Trunk-Ipsilateral Leg and Aortic Extender Components are 20 Fr introducer sheath compatible.
ABOUT W. L. GORE & ASSOCIATES
The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for three decades. During that time, more than 25 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac and general surgery. Gore was recently named one of the best companies to work for by Fortune magazine for the 12th consecutive year. For more information, visit http://www.goremedical.com.
GORE and EXCLUDER(R) are trademarks of W. L. Gore & Associates.
Source: W. L. Gore
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.